Dos Santos Ono R, Dos Santos Moreira N, Carvalho I, Passos G, Sakamoto-Hojo E
J Alzheimers Dis Rep. 2025; 9:25424823241309268.
PMID: 40034521
PMC: 11864261.
DOI: 10.1177/25424823241309268.
Abdel-Maksoud M, Eitah H, Hassan R, Abd-Allah W
Mol Divers. 2025; .
PMID: 39985727
DOI: 10.1007/s11030-025-11121-w.
Arami N, Tajani A, Hashemi M, Rezaei T, Ghodsi R, Soheili V
Mol Biol Rep. 2025; 52(1):175.
PMID: 39883336
DOI: 10.1007/s11033-025-10270-3.
Akhter F, Marufa S, Shohag S, Nishino H, Alam M, Haque M
R Soc Open Sci. 2025; 12(1):241411.
PMID: 39881786
PMC: 11774594.
DOI: 10.1098/rsos.241411.
Capan I, Hawash M, Qaoud M, Jaradat N
ACS Omega. 2025; 10(1):848-861.
PMID: 39829592
PMC: 11739978.
DOI: 10.1021/acsomega.4c07896.
Quinoline-thiosemicarbazone-1,2,3-triazole-acetamide derivatives as new potent α-glucosidase inhibitors.
Khademian A, Halimi M, Azarbad R, Alaedini A, Noori M, Dastyafteh N
Sci Rep. 2024; 14(1):30876.
PMID: 39730503
PMC: 11680592.
DOI: 10.1038/s41598-024-81668-5.
Design and Development of Novel Hybrids Based on Pyrrolo[2,1-f][1,2,4]Triazine and 1-(Methylpiperidin-4-yl) Aniline-Based Analogs: Exploring the Utility as Anticancer Agents via MERTK Inhibition.
Sathe B, Jaiswal S, Kumar D, Singh T, Nainwal N, Rawat P
Chem Biol Drug Des. 2024; 104(6):e70023.
PMID: 39635932
PMC: 11618975.
DOI: 10.1111/cbdd.70023.
The Antiviral and Antimalarial Prodrug Artemisinin from the Species: A Review.
Das G, Shin H, Patra J
Curr Issues Mol Biol. 2024; 46(11):12099-12118.
PMID: 39590312
PMC: 11593081.
DOI: 10.3390/cimb46110718.
Design, synthesis, and evaluation of novel substituted imidazo[1,2-c]quinazoline derivatives as potential α-glucosidase inhibitors with bioactivity and molecular docking insights.
Peytam F, Hosseini F, Fathimolladehi R, Nayeri M, Moghadam M, Bayati B
Sci Rep. 2024; 14(1):27507.
PMID: 39528585
PMC: 11555253.
DOI: 10.1038/s41598-024-78878-2.
Synthesis and Structure of Novel Hybrid Compounds Containing Phthalazin-1(2)-imine and 4,5-Dihydro-1-imidazole Cores and Their Sulfonyl Derivatives with Potential Biological Activities.
Balewski L, Gdaniec M, Hering A, Furman C, Ghinet A, Kokoszka J
Int J Mol Sci. 2024; 25(21).
PMID: 39519047
PMC: 11546079.
DOI: 10.3390/ijms252111495.
NSAIDs between past and present; a long journey towards an ideal COX-2 inhibitor lead.
Khalil N, Ahmed E, Tharwat T, Mahmoud Z
RSC Adv. 2024; 14(42):30647-30661.
PMID: 39324041
PMC: 11423417.
DOI: 10.1039/d4ra04686b.
A nanocarbon-enabled hybridization strategy to construct pharmacologically cooperative therapeutics for augmented anticancer efficacy.
Wang H, Liu X, Yan X, Du Y, Pu F, Ren J
Chem Sci. 2024; .
PMID: 39290590
PMC: 11403576.
DOI: 10.1039/d4sc05280c.
Design, synthesis, and and study of 1-benzyl-indole hybrid thiosemicarbazones as competitive tyrosinase inhibitors.
Batool Z, Ullah S, Khan A, Siddique F, Nadeem S, Alshammari A
RSC Adv. 2024; 14(39):28524-28542.
PMID: 39247501
PMC: 11378339.
DOI: 10.1039/d4ra05015k.
Pharmacological investigation of new niclosamide-based isatin hybrids as antiproliferative, antioxidant, and apoptosis inducers.
Omran M, Kamal M, Ammar Y, Abusaif M, Ismail M, Mansour H
Sci Rep. 2024; 14(1):19818.
PMID: 39191850
PMC: 11349906.
DOI: 10.1038/s41598-024-69250-5.
Novel coumarin-6-sulfonamide-chalcone hybrids as glutathione transferase P1-1 inhibitors.
Sabt A, Kitsos S, Ebaid M, Furlan V, Pantiora P, Tsolka M
PLoS One. 2024; 19(8):e0306124.
PMID: 39141629
PMC: 11324126.
DOI: 10.1371/journal.pone.0306124.
Design, synthesis and biological evaluation of novel pyrazole-based compounds as potential chemotherapeutic agents.
Jaballah M, Elleboudy N, Sharaky M, Abouzid K, Shahin M
Future Med Chem. 2024; 16(13):1299-1311.
PMID: 39109431
PMC: 11318682.
DOI: 10.1080/17568919.2024.2347090.
Design, synthesis, molecular docking and anticancer activities of 1-(4-(benzamido)phenyl)-3-arylurea derivatives.
Sabale P, Sayyad N, Ali A, Sabale V, Kaleem M, Asar T
RSC Adv. 2024; 14(33):23785-23795.
PMID: 39077323
PMC: 11284930.
DOI: 10.1039/d4ra02882a.
Novel Coumarin-Nucleobase Hybrids with Potential Anticancer Activity: Synthesis, In Vitro Cell-Based Evaluation, and Molecular Docking.
Correa de Moraes M, Frassini R, Roesch-Ely M, Reisdorfer de Paula F, Barcellos T
Pharmaceuticals (Basel). 2024; 17(7).
PMID: 39065804
PMC: 11279566.
DOI: 10.3390/ph17070956.
Modulation of the Antimelanoma Activity Imparted to Artemisinin Hybrids by the Monoterpene Counterpart.
De Marchi E, Filippi S, Cesarini S, Di Maio B, Bizzarri B, Saladino R
Molecules. 2024; 29(14).
PMID: 39064999
PMC: 11279807.
DOI: 10.3390/molecules29143421.
Computational Assessment of the Phytochemicals of Panax ginseng C.A. Meyer Against Dopamine Receptor D1 for Early Huntington's Disease Prophylactics.
Adhikari Subin J, Shrestha R
Cell Biochem Biophys. 2024; 82(4):3413-3423.
PMID: 39046621
DOI: 10.1007/s12013-024-01426-2.